Novo Nordisk updates 2030 strategy at London investor day

Novo Nordisk held its 2026 Capital Markets Day — a briefing for investors — in London on 21 September 2026, the company said. The 09:00-15:30 BST (London time) session featured top managers covering strategy, R&D pipeline (drugs in development), operations and performance, plus an update to corporate strategy and 2030 goals.